Kusajili – Clinical trials directory

Result of your search per sponsor: Orion Corporation Orion Pharma, FI-02200 Espoo, Finland

Woman and Man Max 99 years
Orion Corporation Orion Pharma, FI-02200 Espoo, Finland Update Il y a 4 ans

Efficacy and safety of Stalevo in subjects with early wearing-off identified using a screening tool WOQ-9; An open, non-randomised, multinational, multi-centre 6-week direct switch study in levodopa-treated Parkinson's disease patients to provide efficacy data of the direct switch from levodopa/carbidopa or levodopa/benserazide to levodopa/carbidopa/entacapone (Stalevo®) by clinical global impression of change (CGI-C) as judged by t...

Country None
organs None
Specialty None

Closed trial

More information